Influence of diabetes on the pharmacokinetic behavior of natural polyphenols

Current Drug Metabolism

Volumn 15, Issue 1, 2014, Pages 23-29

  Xiao, Jianbo ^a   Högger, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Metabolism; Pharmacokinetic; Polyphenols; Type 2 diabetes

Indexed keywords

AMPICILLIN; ANTHOCYANIN; BAICALIN; BINDING PROTEIN; BREVISCAPINE; CATALPOL; DIAZEPAM; GINKGO BILOBA EXTRACT; GLIPIZIDE; GLUCOSE; HARPAGIDE; IPRIFLAVONE; LIQUIRITIGENIN; MANGIFERIN; METOCLOPRAMIDE; NATURAL POLYPHENOL; ORBIFLOXACIN; OXAZEPAM; PARACETAMOL; PLASMA PROTEIN; POLYPHENOL; POLYPHENOL DERIVATIVE; SULFONYLUREA; TOLAZAMIDE; TRAMADOL; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; BIOLOGICAL ACTIVITY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; HUMAN; INTESTINE FLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN GLYCOSYLATION; PROTEIN INTAKE; PROTEIN METABOLISM; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYPHENOLS;

EID: 84896377472     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200214666131210142614     Document Type: Review

References (72)

1. Flores, F.P.; Singh, R.K.; Kerr, W.L.; Pegg, R.B.; Kong, F.B. Antioxidant and enzyme inhibitory activities of blueberry anthocyanins prepared using different solvents. J. Agric. Food Chem., 2013, 61, 4441-4447.
2. Xiao, J.B.; Ni, X.L.; Kai, G.Y.; Chen, X.Q., A review on structureactivity relationship of dietary polyphenols inhibiting α-amylase. Crit. Rev. Food Sci. Nutr., 2013, 53, 497-506.
3. Xiao, J.B.; Kai, G.Y.; Yamamoto, K.; Chen, X.Q. Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure- activity relationship aspect. Crit. Rev. Food Sci. Nutr., 2013, 53, 818-836.
4. Xiao, J.B.; Ni, X.L.; Kai, G.Y.; Yamamoto, K.; Chen, X.Q. Advance in dietary polyphenols as aldose reductases inhibitors: Structure- activity relationship aspect. Crit. Rev. Food Sci. Nutr., 2013, Doi: 10.1080/10408398. 2010.548108. (In press)
5. Chen, L.; Sun, P.; Wang, T.; Chen, K.X.; Jia, Q.; Wang, H.Y.; Li, Y.M. Diverse mechanisms of antidialbetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice. J. Agric. Food Chem., 2012, 60, 9144-9150.
6. Wahajuddin, Taneja, I.; Arora, S.; Raju, K.S.R.; Siddiqui, N. Disposition of pharmacologically active dietary isoflavones in biological systems. Curr. Drug. Metab., 2013, 14, 369-380.
7. Li, M.; Hagerman, A.E. Interactions between plasma proteins and naturally occurring polyphenols. Curr. Drug. Metab., 2013, 14, 432-445.
8. Xiao, J.B.; Hogger, P. Metabolism of dietary flavonoids in liver microsomes. Curr. Drug. Metab., 2013, 14, 381-391.
9. Xiao, J.B. Polyphenol-plasma proteins interaction: its nature, analytical techniques, and influence on bioactivities of polyphenols. Curr. Drug. Metab., 2013, 14, 366-367.
10. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27, 1047-1053.
11. World Health Organization. Diabetes fact sheet no. 312, March 2013 [online]. Available from URL: http://www.who.int/mediacentre/ factsheets/fs312/en/index.html
12. Bastaki, S. Diabetes mellitus and its treatment. Int. J. Diabetes Metab., 2005, 13, 111-134.
13. Thomas, T.; Pfeiffer, A.F.H. Foods for the prevention of diabetes: how do they work? Diabetes Metab. Res. Rev., 2012, 28, 25-49.
14. Stefek, M. Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip. Toxicol., 2011, 4, 69-77.
15. van Dam, R.M.; Naidoo, N.; Landberg, R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol., 2013, 24, 25-33.
16. Wedick, N.M.; Pan, A.; Cassidy, A.; Rimm, E.B.; Sampson, L.; Rosner, B., et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr., 2012, 95, 925-933.
17. Panagiotakos, D.B.; Lionis, C.; Zeimbekis, A.; Gelastopoulou, K.; Papairakleous, N.; Das, U.N.; et al. Long-term tea intake is associated with reduced prevalence of (type 2) diabetes mellitus among elderly people from Mediterranean islands: MEDIS epidemiological study. Yonsei Med. J., 2009, 50, 31-38.
18. Knekt, P.; Kumpulainen, J.; Jarvinen, R.; et al. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr., 2002, 76, 560-568.
19. van Dam, R.M.; Naidoo, N.; Landberg, R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol., 2013, 24, 25-33.
20. Thomas, T.; Pfeiffer, A. F. Foods for the prevention of diabetes: how do they work? Diabetes Metab. Res. Rev., 2012, 28, 25-49.
21. Aguirre, L.; Arias, N.; Macarulla, M.T.; Gracia, A.; Portillo, M.P. Beneficial effects of quercetin on obesity and diabetes. The Open Nutraceut. J., 2011, 4, 189-198.
22. Schäfer, A.; Högger, P. Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alphaglucosidase. Diabetes Res. Clin. Pract., 2007, 77, 41-46.
23. Cheng, D.M.; Kuhn, P.; Poulev, A.; Rojo, L.E.; Lila, M.A.; Raskin, I. In vivo and in vitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol- enhanced food matrix. Food Chem., 2012, 135, 2994-3002.
24. Chen, L.; Sun, P.; Wang, T.; Chen, K.X.; et al. Diverse mechanisms of antidialbetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice. J. Agric. Food Chem., 2012, 60, 9144-9150.
25. Li, R.; Liang, T.; Xu, L.Y.; Li, Y.W.; Zhang, S.J.; Duan, X.Q. Protective effect of cinnamon polyphenols against STZ-diabetic mice fed high-sugar, high-fat diet and its underlying mechanism. Food Chem. Toxicol., 2013, 51, 419-425.
26. Yilmazer-Musa, M.; Griffith, A.M.; Schneider, E.; Frei, B. Grape seed and tea extracts and catechin 3-gallates are potent inhibitors of alpha-amylase and alpha-glucosidase activity. J. Agric. Food Chem., 2012, 60, 8924-8929.
27. Ding, Y.; Dai, X.Q.; Jiang, Y.F.; Zhang, Z.F.; et al. Grape seed proanthocyanidin extracts alleviate oxidative stress and ER stress in skeletal muscle of low-dose streptozotocin- and highcarbohydrate/ high-fat diet-induced diabetic rats. Mol. Nutr. Food Res., 2013, 57, 365-369.
28. Roopchand, D.E.; Kuhn, P.; Poulev, A.; Oren, A. Biochemical analysis and in vivo hypoglycemic activity of a grape polyphenolsoybean flour complex. J. Agric. Food Chem., 2012, 60, 8860-8865.
29. Cao, H.; Hininger-Favier, I.; Kelly, M.A.; et al. Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J. Agric. Food Chem., 2007, 55, 6372-6378.
30. Hollands, W.J.; Hart, D.J.; Dainty, J.R.; Hasselwander, O.; Tiihonen, K.; Wood, R.; Kroon, P.A. Bioavailability of epicatechin and effects on nitric oxide metabolites of an apple flavanol-rich extract supplemented beverage compared to a whole apple puree: A randomized, placebo-controlled, crossover trial. Mol. Nutr. Food Res., 2013, 57, 1209-1217.
31. Farrell, T.L.; Gomez-Juaristi, M.; Poquet, L.; Redeuil, K.; Nagy, K.; Renouf, M.; Williamson, G. Absorption of dimethoxycinnamic acid derivatives in vitro and pharmacokinetic profile in human plasma following coffee consumption. Mol. Nutr. Food Res., 2012, 56, 1413-1423.
32. Stalmach, A.; Edwards, C.A.; Wightman, J.D.; Crozier, A. Gastrointestinal stability and bioavailability of (poly) phenolic compounds following ingestion of Concord grape juice by humans. Mol. Nutr. Food Res., 2012, 56, 497-509.
33. Dostalek, M.; Akhlaghi, F.; Puzanovova, M. Effect of Diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs. Clin. Pharmacokinet., 2012, 51, 481-499.
34. Hussain, S.A.; Kurji, H.A.H.; Ghareeb, M.M.; Abdulrazzaq, M.H. Effect of acarbose on the bioavailability and pharmacokinetics of metronidazole in healthy and diabetic subjects. Br. J. Pharmaceut. Res., 2012, 2, 41-49.
35. Atif, M.; Ahmad, M.; Qamar-uz-zaman, M.; Asif, M.; Sulaiman, S.A.S.; Shafie, A.A.; Masood, I.; Minhas, U.; Us-saqib, N. Glipizide pharmacokinetics in healthy and diabetic volunteers. Trop. J. Pharmaceut. Res., 2011, 10, 147-152.
36. Lavasani, H.; Sheikholeslami, B.; Ardakani, Y.H.; Abdollahi, M.; Hakemi, L.; Rouini1, M.R. Study of the pharmacokinetic changes of Tramadol in diabetic rats. DARU J. Pharmaceut. Sci., 2013, 21, 17.
37. Gebru, E.; Chang, Z.Q.; Cheng, H.; Lee, J.S.; Kim, J.C.; Park, S.C. Comparative pharmacokinetics of orbifloxacin following a single intravenous oral administration to healthy and diabetic rats. Scand. J. Lab. Anim. Sci., 2011, 38, 99-107.
38. Feng, Y.K.; Liu, Z.Z.; Peng, Y.; Zhang, L.H.; Ju, P.; Bi, K.S.; Chen; X.H. Validated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma: application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction. Biomed. Chromatogr., 2013, DOI: 10.1002/bmc.2949.
39. Harris, K.; Kassis, A.; Major, G.; Chou, C.J. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J. Obesity, 2012, Article ID 879151.
40. Everard, A.; Cani, P.D. Diabetes, obesity and gut microbiota. Best Pract. & Res. Clin. Gastroenterol., 2013, 27, 73-83.
41. Backhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci., 2004, 101, 15718-15723.
42. Shen, J.; Obin, M.S.; Zhao, L. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med., 2013, 34, 39-58.
43. Wu, X.K.; Ma, C.F.; Han, L.; Nawaz, M.; Gao, F.; Zhang, X.Y.; Yu, P.B.; Zhao, C.A.; Li, L.C.; Zhou, A.P.; Wang, J.; Moore, J.E.; Millar, B.C.; Xu, J.R. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol., 2010, 61, 69-78.
44. Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L.; et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and lowgrade inflammation markers. Diabetes, 2010, 59, 3049-3057.
45. Larsen, N.; Vogensen, F.K.; van den Berg, F.W.J.; Nielsen, D.S.; Andreasen, A.S.; Pedersen, B.K.; Al-Soud, W.A.; Sørensen, S.J.; Hansen, L.H.; Jakobsen, M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE, 2010, 5, e9085.
46. Högger, P. Nutrition-derived bioactive metabolites produced by gut microbiota and their potential impact on human health. NUME, 2013, 1, 1-32.
47. Cani, P.D.; Delzenne, N.M. The gut microbiome as therapeutic target. Pharmacol. Therap., 2011, 130, 202-212.
48. Cani, P.D.; Delzenne, N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharmaceut. Design, 2009, 15, 1546-1558.
49. Devaraj, S.; Hemarajata, P.; Versalovic, J. The human gut microbiome and body metabolism: Implications for obesity and diabetes. Clin. Chem., 2013, 59, 617-628.
50. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79, 727-747.
51. Clifford, M.N. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med., 2004, 70, 1103-1114.
52. Radtke, J.; Linseisen, J.; Wolfram, G. Phenolic acid intake of adults in a Bavarian subgroup of the national food composition survey. Z. Ernahrungswiss, 1998, 37, 190-197.
53. Kanakis, C.D.; Hasni, I.; Bourassa, P.; Tarantilis, P.A.; Polissiou, M.G.; Tajmir-Riahi, H.A. Milkbeta-lactoglobulin complexes with tea polyphenols. Food Chem., 2011, 127, 1046-1055.
54. Dubeau, S.; Samson, G.; Tajmir-Riahi, H.A. Dual effect of milk on the antioxidant capacity of green, Darjeeling, and English breakfast teas. Food Chem., 2010, 122, 539-545.
55. Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr., 2005, 45, 287-306.
56. Liu, H.H.; Wu, B.; Pan, G.Y.; He, L.; Li, Z.X.; Fan, M.S.; Jian, L.H.; Chen, M.C.; Wang, K.; Huang, C.G. Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats. Drug Metab. Dispos., 2012, 40, 2109-2118.
57. Xie, Y.X.; Xiao, J.B.; Kai, G.Y.; Chen, X.Q. Glycation of plasma proteins in type II diabetes lowers the non-covalent interaction affinities for dietary polyphenols. Integr. Biol., 2012, 4, 502-507.
58. Wang, Y.L.; Zhao, Y.; Yang, F.; Yuan, Y.M.; Wang, H.; Xiao J.B. Influences of glucose on the dietary hydroxyflavonoids-plasma proteins interaction. J. Agric. Food Chem., 2012, 60, 12116-12221.
59. Du, S.L.; Xie, Y.X.; Chen, X.Q. Influence of glucose on the human serum albumin-flavone interaction and their antioxidant activity. Mol. BioSyst., 2013, 9, 55-60.
60. Xiao, J.B.; Xie, Y.X.; Wang, Y.L.; Cao, H.; Chen, X.Q. Glycation of plasma proteins in diabetics will reduce benefits of antioxidant capacity of natural polyphenols. Free Rad. Biol. Med., 2012, 53(S2), S90.
61. Xiao, J.B.; Xie, Y.X.; Cao, H.; Chen, X.Q. Diabetes can diminish benefits of free radical scavenging potential of polyphenols in blood. Free Rad. Biol. Med., 2012, 53(S1), S67.
62. Lee, D.Y.; Chung, H.J.; Choi, Y.H.; Lee, U.; Kim, S.H.; Lee, I.; Lee, M.G. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin. Eur. J. Pharmaceut. Sci., 2009, 38, 465-471.
63. Kang, H.E.; Sohn, S.I.; Baek, S.R.; Lee, J.W.; Lee, M.G. Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'- diphosphoglucuronic acid level. Metabolism-Clin. Experiment, 2010, 59, 1472-1480.
64. Deng, Y.X.; Shi, Q.Z.; Chen, B.; Zhang, X.J.; Liu, S.Z.; Qiu, X.M. Comparative pharmacokinetics of baicalin in normal and the type 2 diabetic rats after oral administration of the Radix scutellariae extract. Fitoterapia, 2012, 83, 1435-1442.
65. Akao, T.; Kawabata, K.; Yanagisawa, E. Baicalin, the predominant flavone glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol., 2000, 52, 1563-1568.
66. Deng, Y.X.; Yang, C.H.; Mou, L.L. Pharmacokinetic study on baicalin and wogonoside in diabetic rats in vivo after oral administrating Huanglian-Jiedu Decoction. Chin. Trad. Herb Drugs, 2008, 39, 227-231.
67. Liu, L.; Deng, Y.X.; Liang, Y.; Pang, X.Y.; Liu, X.D.; Liu, Y.W., Yang, J.S.; Xie, L.; Wang, G.J. Increased oral AUC of baicalin in streptozotocin- induced diabetic rats due to the increased activity of intestinal-glucuronidase. Planta Med., 2010, 76, 70-75.
68. Deng, Y.X.; Yu, S.; Chen, T.Y.; Liu, L.; Wang, D.L.; Xie, L.; Liu, X.D. Studies on the pharmacokinetic profiles of baicalin and wogonoside in diabetic rats after oral administration of extract of Scutellariae Radix. Chin. J. New Drugs, 2007, 16, 1573-1577.
69. Tang, D.; Yin, Y.; Zhang, Z.; Gao, Y.; Wei, Y.; Chen, Y.; Han, L. Simultaneous HPLC-DAD analysis of five flavonoids in diabetic rat plasma and its application in the study of pharmacokinetics. Acta Chromatograph., 2009, 21, 483-497.
70. Tang, D.Q.; Yin, X.X.; Zhang, Z.J.; Gao, Y.Y.; Wei, Y.Q; Chen, Y.G.; Han, L. Comparative study on the pharmacokinetics of Ginkgo biloba extract between normal and diabetic rats by HPLCDAD. Lat. Am. J. Pharm., 2009, 28, 400-408.
71. Wang, X.B.; Zhang, F.; Zhao, X.R.; Wei, Y.H. Pharmacokinetics of breviscapine in normal and diabetic rats. J. Lanzhou Univ. (Med. Sci.), 2013, 39(2), 41-44.
72. Park, J.H.; Choi, Y.J.; Kim, Y.W.; Kim, S.P.; Cho, H.C.; Ahn, S.; Bae, K.C.; Im, S.S.; Bae, J.H. ; Song, D.K. Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice. NAUNYNSCHMIEDEBERGS Arch. Pharmacol., 2013, 386, 733-745.